- Home
- DRIO vs NNVC Comparison
DRIO vs NNVC Comparison
Compare DRIO & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- NNVC
- Stock Information
- Founded
- DRIO 2011
- NNVC 2005
- Country
- DRIO United States
- NNVC United States
- Employees
- DRIO N/A
- NNVC N/A
- Industry
- DRIO Medical/Dental Instruments
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- NNVC Health Care
- Exchange
- DRIO Nasdaq
- NNVC Nasdaq
- Market Cap
- DRIO 30.5M
- NNVC 24.4M
- IPO Year
- DRIO N/A
- NNVC N/A
- Fundamental
- Price
- DRIO $0.71
- NNVC $1.41
- Analyst Decision
- DRIO Strong Buy
- NNVC
- Analyst Count
- DRIO 2
- NNVC 0
- Target Price
- DRIO $2.50
- NNVC N/A
- AVG Volume (30 Days)
- DRIO 168.4K
- NNVC 243.9K
- Earning Date
- DRIO 08-07-2025
- NNVC 05-15-2025
- Dividend Yield
- DRIO N/A
- NNVC N/A
- EPS Growth
- DRIO N/A
- NNVC N/A
- EPS
- DRIO N/A
- NNVC N/A
- Revenue
- DRIO $28,034,000.00
- NNVC N/A
- Revenue This Year
- DRIO $13.66
- NNVC N/A
- Revenue Next Year
- DRIO $24.50
- NNVC N/A
- P/E Ratio
- DRIO N/A
- NNVC N/A
- Revenue Growth
- DRIO 47.20
- NNVC N/A
- 52 Week Low
- DRIO $0.50
- NNVC $0.94
- 52 Week High
- DRIO $1.55
- NNVC $2.55
- Technical
- Relative Strength Index (RSI)
- DRIO 44.44
- NNVC 49.12
- Support Level
- DRIO $0.67
- NNVC $1.32
- Resistance Level
- DRIO $0.73
- NNVC $1.42
- Average True Range (ATR)
- DRIO 0.04
- NNVC 0.10
- MACD
- DRIO -0.00
- NNVC -0.01
- Stochastic Oscillator
- DRIO 38.46
- NNVC 61.90
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.